Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune
- PMID: 38282191
- PMCID: PMC10758016
- DOI: 10.1002/clt2.12327
Clinical characteristics of allergic bronchopulmonary mycosis caused by Schizophyllum commune
Abstract
Background: Allergic bronchopulmonary mycosis (ABPM) is an allergic disease caused by type I and type III hypersensitivity to environmental fungi. Schizophyllum commune, a basidiomycete fungus, is one of the most common fungi that causes non-Aspergillus ABPM.
Objective: Herein, we attempted to clarify the clinical characteristics of ABPM caused by S. commune (ABPM-Sc) compared with those of allergic bronchopulmonary aspergillosis (ABPA).
Methods: Patients with ABPM-Sc or ABPA were recruited from a nationwide survey in Japan, a multicenter cohort, and a fungal database at the Medical Mycology Research Center of Chiba University. The definition of culture-positive ABPM-Sc/ABPA is as follows: (1) fulfills five or more of the 10 diagnostic criteria for ABPM proposed by Asano et al., and (2) positive culture of S. commune/Aspergillus spp. in sputum, bronchial lavage fluid, or mucus plugs in the bronchi.
Results: Thirty patients with ABPM-Sc and 46 with ABPA were recruited. Patients with ABPM-Sc exhibited less severe asthma and presented with better pulmonary function than those with ABPA (p = 0.008-0.03). Central bronchiectasis was more common in ABPM-Sc than that in ABPA, whereas peripheral lung lesions, including infiltrates/ground-glass opacities or fibrotic/cystic changes, were less frequent in ABPM-Sc. Aspergillus fumigatus-specific immunoglobulin (Ig)E was negative in 10 patients (34%) with ABPM-Sc, who demonstrated a lower prevalence of asthma and levels of total serum IgE than those with ABPM-Sc positive for A. fumigatus-specific IgE or ABPA.
Conclusions: Clinical characteristics of ABPM-Sc, especially those negative for A. fumigatus-specific IgE, differed from those of ABPA.
Keywords: Aspergillus; Schizophyllum commune; allergic bronchopulmonary aspergillosis; allergic bronchopulmonary mycosis; asthma.
© 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures

Similar articles
-
Allergic bronchopulmonary mycosis in Schizophyllum commune with positive Aspergillus-specific IgE antibodies: A case report.Respirol Case Rep. 2024 Jul 16;12(7):e01433. doi: 10.1002/rcr2.1433. eCollection 2024 Jul. Respirol Case Rep. 2024. PMID: 39015483 Free PMC article.
-
Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?Intern Med. 2025 Feb 15;64(4):493-501. doi: 10.2169/internalmedicine.4386-24. Epub 2024 Sep 4. Intern Med. 2025. PMID: 39231658 Free PMC article. Review.
-
Roles of Mycological and Pathological Examinations of Bronchoscopic Specimens in the Diagnosis of Allergic Bronchopulmonary Aspergillosis/Mycosis.J Allergy Clin Immunol Pract. 2025 Aug;13(8):2004-2011.e1. doi: 10.1016/j.jaip.2025.04.025. Epub 2025 Apr 24. J Allergy Clin Immunol Pract. 2025. PMID: 40287062
-
Allergic bronchopulmonary aspergillosis in Japan: A nationwide survey.Allergol Int. 2018 Jan;67(1):79-84. doi: 10.1016/j.alit.2017.04.011. Epub 2017 May 23. Allergol Int. 2018. PMID: 28546015 Clinical Trial.
-
Fungi and allergic lower respiratory tract diseases.J Allergy Clin Immunol. 2012 Feb;129(2):280-91; quiz 292-3. doi: 10.1016/j.jaci.2011.12.970. J Allergy Clin Immunol. 2012. PMID: 22284927 Review.
Cited by
-
Allergic bronchopulmonary mycosis in Schizophyllum commune with positive Aspergillus-specific IgE antibodies: A case report.Respirol Case Rep. 2024 Jul 16;12(7):e01433. doi: 10.1002/rcr2.1433. eCollection 2024 Jul. Respirol Case Rep. 2024. PMID: 39015483 Free PMC article.
-
Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses.Eur Respir J. 2024 Apr 4;63(4):2400061. doi: 10.1183/13993003.00061-2024. Print 2024 Apr. Eur Respir J. 2024. PMID: 38423624 Free PMC article.
-
Recurrent Pulmonary Infection Caused by Schizophyllum commune: A Case Report and Management of Inflammation.Respirol Case Rep. 2025 Jul 3;13(7):e70239. doi: 10.1002/rcr2.70239. eCollection 2025 Jul. Respirol Case Rep. 2025. PMID: 40620747 Free PMC article.
-
Allergic Bronchopulmonary Aspergillosis/Mycosis: An Allergic Disease or an Eosinophilic Disease?Intern Med. 2025 Feb 15;64(4):493-501. doi: 10.2169/internalmedicine.4386-24. Epub 2024 Sep 4. Intern Med. 2025. PMID: 39231658 Free PMC article. Review.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous